A Study to Examine Changes in GIP Plasma Levels Following Gastric Bypass Surgery in Obese Patients
A Pilot Study to Examine the Relationship Between Changes in Plasma GIP Levels and Other Gastrointestinal Peptides Following Gastric Bypass Surgery in Obese Patients
Sponsor: Boston Medical Center
Terminated
Insufficient funding
Other terminated trials from Boston Medical Center
Other Insulin Resistance trials with similar outcome
Listed as NCT00207389, this observational or N/A phase trial focuses on Insulin Resistance and Obesity and remains terminated or withdrawn. Sponsored by Boston Medical Center, it has been updated 7 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
▶ Show 2 earlier versions
-
Feb 2017 — Apr 2018 [monthly]
Terminated NA
Status: Suspended → Terminated
-
Jan 2017 — Feb 2017 [monthly]
Suspended NA
First recorded
Mar 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .